Preliminary study finds a clue in the quest to help diagnose CTE in the
living
[November 14, 2026]
By LAURAN NEERGAARD
WASHINGTON (AP) — Scientists stumbled onto a hint that measuring a toxic
protein tied to Alzheimer’s disease just might one day be useful in
diagnosing a different brain disease in football players and others who
have suffered repeated blows to the head.
Doctors evaluate symptoms such as mood swings and memory loss to try to
tell if patients may have CTE, or chronic traumatic encephalopathy, a
disease linked to concussions and other brain trauma. But other diseases
cause similar symptoms, and a CTE diagnosis can only be confirmed by
examining the brain after death.
The new clue involves a protein called tau that normally supports
neurons but becomes abnormal in Alzheimer’s, tangling inside those nerve
cells. Researchers at Washington University in St. Louis were using
autopsy samples to study a tau fragment called eMTBR-tau243 that may
help track those tangles when they found something unusual: a patient
with high levels of that biomarker even though records showed the person
didn’t have Alzheimer’s but advanced CTE instead.
The researchers turned to a larger collection of autopsied brain and
other samples, and eventually tested blood stored from 11 people who had
been classified as having CTE.
Compared to healthy people, levels of eMTBR-tau243 were higher in those
with advanced CTE, said study coauthor Chihiro Sato, a WashU assistant
neurology professor. That biomarker couldn’t reliably identify
early-stage CTE.

[to top of second column]
|

A human brain affected by Alzheimer's disease is displayed at the
Museum of Neuroanatomy at the University at Buffalo in Buffalo,
N.Y., on Oct. 7, 2003. (AP Photo/David Duprey, File)
 It is an interesting but very
preliminary finding, requiring far larger studies to see if there is
a real connection, cautioned Dr. Rudolph Castellani, a
neuropathologist at Northwestern University who wasn’t involved with
the research.
Abnormal tau is found in several brain diseases, many of which can
overlap in older adults, adding to the difficulty in teasing apart
its role in any one disease, including CTE. Sato, who studies such
tauopathies, also stressed much more research is needed.
The findings were published late Friday by the medical journal JAMA
and presented at a scientific meeting in Japan.
All contents © copyright 2026 Associated Press. All rights reserved |